Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Return on Capital Employed (2016 - 2025)

BioCorRx's Return on Capital Employed history spans 15 years, with the latest figure at 0.68% for Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 5.0% year-over-year to 0.68%; the TTM value through Sep 2025 reached 0.68%, up 5.0%, while the annual FY2024 figure was 0.66%, 1.0% up from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.68% at BioCorRx, up from 0.66% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 9.98% in Q2 2021 and bottomed at 0.52% in Q1 2025.
  • The 5-year median for Return on Capital Employed is 0.82% (2023), against an average of 1.81%.
  • The largest annual shift saw Return on Capital Employed surged 2705bps in 2021 before it crashed -854bps in 2022.
  • A 5-year view of Return on Capital Employed shows it stood at 1.73% in 2021, then plummeted by -41bps to 1.03% in 2022, then plummeted by -38bps to 0.63% in 2023, then grew by 5bps to 0.67% in 2024, then rose by 3bps to 0.68% in 2025.
  • Per Business Quant, the three most recent readings for BICX's Return on Capital Employed are 0.68% (Q3 2025), 0.66% (Q2 2025), and 0.52% (Q1 2025).